COVID-19 Pneumonia and Tocilizumab use: Case Report
Keywords:COVID-19, tocilizumab, interleukin 6 antagonists and inhibitors
We present the case of an adult patient with COVID-19 pneumonia with rapid clinical-radiological progression, in whom the compassionate use of interleukin receptor blocker 6 (Tocilizumab) was used for the management of his disease.
Copyright (c) 2020 Ursula Cáceres Bernaola, Claudia Becerra Núñez, Sabina Mendívil-Tuchía de Tai, Jorge Ravelo-Hernández
This work is licensed under a Creative Commons Attribution 4.0 International License.